WATCH: Experts delve into federal drug pricing program
Colorado Politics and PhRMA hosted a panel discussion on November 12, 2024, with industry experts on the dynamics in the health care system that are driving higher health care costs and leaving patients behind.
Luige Del Puerto luige.delpuerto@coloradopolitics.com
A panel of experts discussed the state and national effects that the drug pricing program known as 340B is having on the healthcare industry during a breakfast hosted by Colorado Politics in Downtown Denver this month.
The program developed in the 1990s allowing healthcare organizations to purchase discounted outpatient drugs to help low-income patients has grown into a system of abuse and misuse without government oversight, according to industry insiders.
The federal 340B Drug Pricing Program allows eligible healthcare organizations to purchase outpatient drugs at a discount from manufacturers. The program was established in 1992 as part of the Public Health Service Act.